Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C B Granger

Showing results (111-120 of 133) with videos related to

Pageof 14
Sort By:
Stroke|March 20, 1998
Thrombolysis-related intracranial hemorrhage: a radiographic analysis of 244 cases from the GUSTO-1 trial with clinical correlation. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary ArteriesJ M Gebel, C A Sila, M A Sloan, et al.
Journal of the American College of Cardiology|July 14, 2001
Prognostic value of ST segment depression in acute coronary syndromes: insights from PARAGON-A applied to GUSTO-IIb. PARAGON-A and GUSTO IIb Investigators. Platelet IIb/IIIa Antagonism for the Reduction of Acute Global Organization NetworkP Kaul, Y Fu, W C Chang, et al.
JAMA|March 3, 1999
Prognostic value of the admission electrocardiogram in acute coronary syndromesS Savonitto, D Ardissino, C B Granger, et al.
American Heart Journal|November 30, 1999
Racial differences in the management of unstable angina: results from the multicenter GUARANTEE registryB M Scirica, D J Moliterno, N R Every, et al.
The New England Journal of Medicine|October 31, 1996
Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA InvestigatorsE M Ohman, P W Armstrong, R H Christenson, et al.
The American Journal of Cardiology|December 14, 2001
Comparison of benefits and complications of hirudin versus heparin for patients with acute coronary syndromes undergoing early percutaneous coronary interventionM T Roe, C B Granger, J A Puma, et al.
Journal of Thrombosis and Haemostasis : JTH|June 20, 2014
D-dimer and risk of thromboembolic and bleeding events in patients with atrial fibrillation--observations from the ARISTOTLE trialC Christersson, L Wallentin, U Andersson, et al.
Circulation|October 7, 1998
Prediction of 30-day mortality among patients with thrombolysis-related intracranial hemorrhageM A Sloan, C A Sila, K W Mahaffey, et al.
American Heart Journal|November 30, 1999
A randomized trial of ecadotril versus placebo in patients with mild to moderate heart failure: the U.S. ecadotril pilot safety studyC M O'Connor, W A Gattis, M Gheorghiade, et al.
The American Journal of Cardiology|June 27, 2000
Use of resources, quality of life, and clinical outcomes in patients with and without new Q waves after thrombolytic therapy for acute myocardial infarction (from the GUSTO-I trial)A Barbagelata, R M Califf, E B Sgarbossa, et al.
Pageof 14

Showing results (111-120 of 133) with videos related to

Sort By:
Pageof 14
Stroke|March 20, 1998
Thrombolysis-related intracranial hemorrhage: a radiographic analysis of 244 cases from the GUSTO-1 trial with clinical correlation. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary ArteriesJ M Gebel, C A Sila, M A Sloan, et al.
Journal of the American College of Cardiology|July 14, 2001
Prognostic value of ST segment depression in acute coronary syndromes: insights from PARAGON-A applied to GUSTO-IIb. PARAGON-A and GUSTO IIb Investigators. Platelet IIb/IIIa Antagonism for the Reduction of Acute Global Organization NetworkP Kaul, Y Fu, W C Chang, et al.
JAMA|March 3, 1999
Prognostic value of the admission electrocardiogram in acute coronary syndromesS Savonitto, D Ardissino, C B Granger, et al.
American Heart Journal|November 30, 1999
Racial differences in the management of unstable angina: results from the multicenter GUARANTEE registryB M Scirica, D J Moliterno, N R Every, et al.
The New England Journal of Medicine|October 31, 1996
Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA InvestigatorsE M Ohman, P W Armstrong, R H Christenson, et al.
The American Journal of Cardiology|December 14, 2001
Comparison of benefits and complications of hirudin versus heparin for patients with acute coronary syndromes undergoing early percutaneous coronary interventionM T Roe, C B Granger, J A Puma, et al.
Journal of Thrombosis and Haemostasis : JTH|June 20, 2014
D-dimer and risk of thromboembolic and bleeding events in patients with atrial fibrillation--observations from the ARISTOTLE trialC Christersson, L Wallentin, U Andersson, et al.
Circulation|October 7, 1998
Prediction of 30-day mortality among patients with thrombolysis-related intracranial hemorrhageM A Sloan, C A Sila, K W Mahaffey, et al.
American Heart Journal|November 30, 1999
A randomized trial of ecadotril versus placebo in patients with mild to moderate heart failure: the U.S. ecadotril pilot safety studyC M O'Connor, W A Gattis, M Gheorghiade, et al.
The American Journal of Cardiology|June 27, 2000
Use of resources, quality of life, and clinical outcomes in patients with and without new Q waves after thrombolytic therapy for acute myocardial infarction (from the GUSTO-I trial)A Barbagelata, R M Califf, E B Sgarbossa, et al.
Pageof 14